Vitreous-Retina-Macula Consultants of New York PC

Specializes in vitreoretinal diagnosis and surgery

Vitreous-Retina-Macula Consultants of New York PC

Specializes in vitreoretinal diagnosis and surgery

Overview

VRMNY provides specialized eye care for retinal diseases, diagnosing conditions like macular degeneration and diabetic retinopathy and performing vitreoretinal surgeries, with medical management as needed. Its physicians are active in teaching at major hospitals, and the practice operates multiple New York City centers, making it the largest retina and vitreous center in the New York metro area. The team differentiates itself through leaders' academic credentials and deep surgical expertise connected to Lenox Hill, NYU, and NY Eye and Ear Infirmary. The goal is to diagnose, treat, and manage retinal diseases to preserve and restore vision and improve patient outcomes across its network of locations.

Work here?Claim your company

About Vitreous-Retina-Macula Consultants of New York PC

Simplify's Rating

Why Vitreous-Retina-Macula Consultants of New York PC is rated

B-

Rated B on Competitive Edge

Rated B on Growth Potential

Rated C on Differentiation

Industries

Healthcare

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

1974

Get referred to Vitreous-Retina-Macula Consultants of New York PC

See people who can refer or advise you

Simplify's take

What believers are saying

On August 19, 2026, VRMNY started MAKO recruitment for newly diagnosed wet AMD.
On August 19, 2026, VRMNY began BOULEVARD recruitment for diabetic macular edema.
On August 6, 2026, Dr. Marc Mardelli joined, expanding Scarsdale and New City capacity.

What critics are saying

MAKO and BOULEVARD depend on sponsor-funded enrollment; slow recruitment cuts trial revenue immediately.
Retina care is procedurally commoditized; competing groups like VRCNY and academic centers poach referrals.
If Northwell referral preferences shift, VRMNY loses patient flow and regional negotiating leverage.

What makes Vitreous-Retina-Macula Consultants of New York PC unique

VRMNY runs ten New York sites and anchors Northwell Health retina referrals.
Its 2026 MAKO and BOULEVARD trials give patients experimental wet AMD and DME therapies.
Retina Consultants of America membership strengthens recruitment, purchasing power, and physician hiring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match
Dental Insurance
Flexible Spending Account
Health Insurance
Life Insurance
Parental Leave
Health Savings Account
Vision Insurance

Company News

PR Newswire

Feb 20th, 2024

Richard F. Spaide, Md Of The Vitreous Retina Macula Consultants Of New York Awarded The Arnall Patz Medal By The Macula Society

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist Richard F. Spaide, MD, was awarded the Arnall Patz Medal at The Macula Society 's 47th Annual Meeting on February 9th, 2024.Dr. Spaide was selected as the honoree of the Arnall Patz Medal by the awards committee of The Macula Society. The Macula Society is the preeminent organization for specialists in the field of macula and retinal diseases. The Arnall Patz Medal is awarded to those who have made outstanding contributions to the understanding of retinal vascular diseases in honor of ophthalmologist Arnall Patz, who is known for his landmark work on retinopathy of prematurity.Dr

PR Newswire

Jan 5th, 2024

Vitreous Retina Macula Consultants Of New York'S K. Bailey Freund, Md Serves As Program Director Of The Atlantic Coast Retina Club (Acrc) And Macula Conference

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist K. Bailey Freund, MD will serve as the Program Director of the 48th Annual Atlantic Coast Retina Club (ACRC) & 24th Macula Conference (Macula 2024).The ACRC was originally co-founded by Lawrence Yannuzzi, MD, co-founder of VRMNY, as a one-day Friday conference open to all retinal specialists. Twenty-three years after the first ACRC meeting, Dr. Yannuzzi created a Saturday program and Macula 2000 was born.The Conference will take place from January 4th through the 6th at the New York Academy of Medicine, 1216 5th Avenue in New York City.Expected to attract between 400-500 retina specialists from around the world, the meetings' participants will learn about new therapies, recent clinical trial results, artificial intelligence, and the latest retinal imaging technologies. The goal of the conference is to help clinicians better manage their patients with macular and retinal disorders and achieve better patient outcomes in their practices."Our meeting this year promises to provide new insight into current critical issues which are inherent in retinal diseases and their treatments," said K

PR Newswire

Oct 17th, 2023

Vitreous Retina Macula Consultants Of New York Announces Participation In Wet Amd Study In Collaboration With Regenxbio

Currently Enrolling Patients Suffering from Wet Age-Related Macular DegenerationNEW YORK, Oct. 17, 2023 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that they have been selected to participate in an innovative Wet AMD study in collaboration with Regenxbio. Wet age-related macular degeneration (wet AMD) is a severe visual impairment caused by the development of new leaky blood vessels in the retina, an essential tissue responsible for vision.VRMNY will be the only Manhattan-based site to participate in the study, which will offer an investigational therapy to patients. The therapy is designed to deliver a targeted gene directly to the retina, in order for these cells to produce an anti-VEGF protein. This groundbreaking approach has the potential to reduce, or even eliminate, the frequent need for anti-VEGF injections, which are the current standard of care for wet AMD.Dr. Richard F

Recently Posted Jobs